For appointments

Call the office

Folsom, California Office: 916-983-4444

Call Now

Close

WHO:

Dr. Gish is a Hepatologist specializing in all forms of liver disease, liver cancer and liver transplant. Dr. Gish has partnered with TeleMed2U to provide telemedicine consultative services for patients with liver disease.

WHAT:

TeleMed2U is a telemedicine-based multi-specialty clinical practice increasing access to specialist providers providing, “healthcare anywhere and everywhere.” The telemedicine consultation will be conducted through our HIPAA and HITECH compliant platform. Connectivity testing will be done in advance to ensure you can connect via our telemedicine platform. Following the consultation, a clinical note will be provided including a summary of your liver consultation with Dr. Gish and his consultative recommendations.

COST:

Payment will be processed through an online secure transaction portal. The fees for consultative services are:

Initial 60 minute consultation per patient: $500.00
Follow Up 30 minute consultation per patient: $300.00

NEXT STEPS:

If you’d like to continue, please click Next to complete the form and we will contact you to schedule connectivity testing. During the test you will have the opportunity to determine the method of providing medical records, discuss appointment availability as well as discuss any additional questions that you have. If you are a healthcare facility interested in services, please complete the form and we can discuss the options that are right for you and your patients.

Email

Subject

Country

You should be aware of the general risks of transmitting information over the Internet, which may not use encryption. You should therefore not share any personal medical information that you would wish to be held confidential in a physician/patient or similar clinical relationship.

The information contained on this website is not intended, should not substitute for, or be used instead of, a clinical or therapeutic relationship with a health care professional who is fully familiar with the specifics of your case. The information on this site may assist you in your personal, general research but none of it constitutes the practice of medicine or any other health care profession.

Nothing in this site is intended as a recommendation or endorsement of any specific tests, products, procedures, healthcare provider, opinions, or other information that may be mentioned in this site. Any reliance on any information provided by the website personnel, others appearing on the site at the invitation of the website and/or other visitors to the site is solely at the user's risk.

E-mail correspondence with Dr. Robert G. Gish Consultants, LLC or any of its employees, or agents, does not create a physician/patient relationship between us or cause Dr. Gish to create or retain any medical records about you, monitor your care, or communicate with your own health care provider.

Always seek the advice of your physician or other qualified health care provider with any questions you have regarding your medical care. If you suspect that you may have a medical condition, or are seeking medical advice or treatment, we recommend that you consult a qualified health professional as soon as possible.

Powered by

Close Form

Nominations for the Distinguished Award in Hepatitis B Research are still open!

Jan 23, 2017

The deadline for nominations is February 13, 2017. Please submit your nomination to Polly Ranson at info@hbvmeeting.org.

We encourage you participate in this newly established award and send in your nomination.

Award announcement:

We would like to announce the establishment of a “Distinguished Award in Hepatitis B Research” that will be given during the International HBV Meeting on a yearly basis. The Awardee will receive a plaque and, provided that funding is available, financial support from the meeting organizers for travel and accommodation to the meeting.

The selection criteria are:

Seminal scholarly contributions to the field of HBV research, as judged by the impact of publications.
Long-standing member of the HBV research community, who is recognized as a prominent leader, with a large body of work that has made continuous contributions to the field.
Frequent participation in the annual International HBV Meeting.
Strong commitment to serve, build and support the HBV research community, as recognized by various non-research contributions to the field.

Retired and active researchers are eligible for nomination. Nominations can be submitted by any past attendee of the International HBV Meeting, with a brief nomination letter (one-page) and the nominee’s CV. Joint nomination of two researchers will be considered only under clearly extraordinary conditions and such joint awards will be given only very rarely.Permission must be obtained from the nominee prior to nomination, and self-nomination is discouraged. Candidates who were not selected can be re-nominated in subsequent years.

The nominations will be reviewed and judged by a Selection Committee composed of:

The current Scientific Advisory Council

The current meeting organizers

Two ad hoc members (selected by the Scientific Advisory Council)

Review process:

The Selection Committee will not take an active role in nominating candidates.
The review process will be co-chaired by the Chair of the Scientific Advisory Council plus one of the current year’s meeting organizers.
The review process will be held in strict confidence by the Selection Committee members. The Selection Committee members will absolutely maintain confidentiality of the selection until the selected candidate is announced publicly by the committee.
If members of the Selection Committee are nominated for the award, they will take no part in the review process and additional members will be recruited to the Selection Committee by the rest of the committee.
If a Selection Committee member is in the same institution or has co-authored a research article (not review article or commentary) in the last two years with one of the candidates, he or she will abstain from voting on the candidate but can vote on the other candidates. If one of the chairs is in conflict with one of the candidates, the co-chair will manage the discussion and voting for that candidate.
After the selection is announced, the Selection Committee, via its chairs, can privately encourage those candidates who were on the shortlist but not selected to be re-nominated in the future.

Contact:

Polly Ranson, Meeting Secretariat

Hepatitis B Foundation

3805 Old Easton Road

Doylestown, PA 18902 USA

Tele (215) 489-4900

info@hbvmeeting.org

Metadata